12 February 2026 – 1 mins read
PARIS, FRANCE, 12 February 2026 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the full year (FY) 2025 and for the fourth quarter of 2025.
The Ipsen FY 2025 Results Call will take place on February 12th, from 2:00 to 3:00pm CET.
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries, and our partnerships around the world, enable us to bring medicines to patients in more than 100 countries.
If you are experiencing difficulties registering for the investor and analyst conference call, please contact: khalid.deojee@ipsen.com
Vice President, Investor Relations
Senior Manager, Investor Relations
YTD 2025 sales
H1 2025
Q1 2025
FY 2024
Capital Markets Day 2023
YTD 2024 sales
H1 2024 results
Dividend payment date
Ex-dividend date
Annual General Meeting
